To evaluate the extent to which a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory breathing exercises compared to expiratory breathing exercises alone will help to improve shortness of breath, respiratory symptoms, breathing function, distance walked, and quality of life in those who are experiencing persistent shortness of breath after having had COVID-19. Measurements will take place at the beginning, 6 weeks, and at 12 weeks in the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Modified Medical Research Council Scale
Timeframe: Baseline, 6-weeks, and 12-week measurements
COPD Assessment Test
Timeframe: Baseline, 6-weeks, and 12-week measurements.
Forced Expiratory Volume over 1 second (FEV1)
Timeframe: Baseline, 6-weeks, and 12-week measurements
Peak Inspiratory Flow
Timeframe: Baseline, 6-weeks, and 12-week measurements.
Thoracic Expansion Measures
Timeframe: Baseline, 6-weeks, and 12-week measurements
Physical Capacity
Timeframe: Baseline, 6-weeks, and 12-week measurements.
EuroQoL-5 Dimension-5 Level
Timeframe: Baseline, 6-weeks, and 12-week measurements.